Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer (Q36955125)

17 August 2017

Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer (English)

1 reference

17 August 2017

1 reference

1 reference

Graham A Colditz

10

0 references

Rulla M Tamimi

1

object named as

Rulla M Tamimi

1 reference

17 August 2017

9

Stuart J Schnitt

1 reference

17 August 2017

2

Heather J Baer

1 reference

17 August 2017

3

Jonathan Marotti

1 reference

17 August 2017

11

Laura C Collins

1 reference

17 August 2017

Mark Galan

4

1 reference

17 August 2017

Laurie Galaburda

5

1 reference

17 August 2017

Yineng Fu

6

1 reference

17 August 2017

Anne C Deitz

7

1 reference

17 August 2017

James L Connolly

8

1 reference

17 August 2017

5 August 2008

1 reference

17 August 2017

Breast Cancer Research

1 reference

17 August 2017

10

1 reference

17 August 2017

4

1 reference

17 August 2017

R67

1 reference

https://scigraph.springernature.com/pub.10.1186/bcr2128

17 August 2017

0 references

cites work

Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575540

Abrogated response to cellular stress identifies DCIS associated with subsequent tumor events and defines basal-like breast tumors

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575540

Epidemiology of basal-like breast cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575540

Pathological and biological differences between screen-detected and interval ductal carcinoma in situ of the breast

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575540

Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575540

Molecular classification and molecular forecasting of breast cancer: ready for clinical application?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575540

High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575540

Repeated observation of breast tumor subtypes in independent gene expression data sets

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575540

Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575540

Breast carcinoma in situ: risk factors and screening patterns

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575540

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575540

Distinctive gene expression patterns in human mammary epithelial cells and breast cancers

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575540

Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575540

Expression of cytokeratin markers, ER-alpha, PR, HER-2/neu, and EGFR in pure ductal carcinoma in situ (DCIS) and DCIS with co-existing invasive ductal carcinoma (IDC) of the breast

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575540

Differences in risk factors for breast cancer molecular subtypes in a population-based study

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575540

Identification of a basal-like subtype of breast ductal carcinoma in situ

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575540

P-cadherin and cytokeratin 5: useful adjunct markers to distinguish basal-like ductal carcinomas in situ.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575540

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575540

Expression of luminal and basal cytokeratins in human breast carcinoma

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575540

Risk factors for in situ breast cancer

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2575540

Ductal carcinoma in situ with basal-like phenotype: a possible precursor to invasive basal-like breast cancer

27 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2FBCR2128

Risk factors for breast cancer according to estrogen and progesterone receptor status

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2FBCR2128

Incidence of and treatment for ductal carcinoma in situ of the breast.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2FBCR2128

Screening-detected and symptomatic ductal carcinoma in situ: mammographic features with pathologic correlation

21 January 2018

1 reference

12 December 2020

Correlations between the mammographic features of ductal carcinoma In situ (DCIS) and C-erbB-2 oncogene expression

1 reference

12 December 2020

Mammographically-detected ductal in situ carcinoma of the breast analyzed with a new classification. A study of 127 cases: correlation with estrogen and progesterone receptors, p53 and c-erbB-2 proteins, and proliferative activity

1 reference

12 December 2020

Twenty-year follow-up of the Royal Marsden randomized, double-blinded tamoxifen breast cancer prevention trial

1 reference

12 December 2020

Identifiers

DOI

10.1186/BCR2128

1 reference

Dimensions Publication ID

17 August 2017

0 references

1 reference

17 August 2017

1 reference